ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorCaranx Medical

About this trial

The TAVIPILOT tele-operated robot by Caranx Medical is an advanced intraoperative robotic assistance system designed to enhance the precision of transcatheter aortic valve positioning during TAVR. The system integrates with standard procedural workflows and enables remote manipulation of delivery system components, allowing for controlled, stable, and reproducible movements. TAVIPILOT facilitates accurate valve alignment and deployment, reducing operator variability. The robot is compatible with approved balloon-expandable transcatheter heart valves (Sapien 3 and Ultra, Edwards Lifesciences, USA) and standard catheterization lab infrastructure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥65

Indicated for transfemoral TAVR for severe aortic stenosis

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • TAVR using a tele-operated Robot

    Device

    TAVR procedure with TAVIPILOT tele-operated robot by Caranx Medical enhancing the precision of transcatheter aortic valve positioning during TAVR.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Use of tele-operated TAVIPILOT Robot during the procedureExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Investigational Device Safety

The primary objective is to evaluate investigational device-related safety, including the occurrence of investigational device-related conversion to open-heart surgery, investigational device-related valve embolization and investigational device-related trauma during progression through the ascending aorta and the native valve.

Time frame
Periprocedural
2

Investigational Device Safety

The investigational device-related safety will also be assessed by verifying the absence of major technical malfunctions.

Time frame
Periprocedural

Secondary outcomes

1

Device Usability

Evaluate clinical usability, assessed through customized questionnaires measuring clinician satisfaction, perceived ease of use, and integration of the devices into the procedural workflow.

Time frame
Periprocedural

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: